Skip to main content
Back to News

News From Around the System

Expanding Treatment Options for Severe Brain Trauma

UC San Diego Health — July 23, 2020

Researchers at UC San Diego Health have joined a national research study called Hyperbaric Oxygen Brain Injury Treatment (HOBIT) to assess whether therapy involving 100 percent oxygen under pressure might also benefit patients with severe brain injuries.

UCI Anti-Cancer Challenge goes virtual for 2020

UCI Health — July 21, 2020

UCI Anti-Cancer Challenge, a movement to raise awareness and funds for cancer research, is going virtual for 2020 in order to maintain social distancing and safeguard participant health. The reimagined Anti-Cancer Challenge now includes an eight-week virtual fundraising and wellness program that connects people around the local community and across…

Providing choice for patients facing kidney failure

UCI Health — July 20, 2020

A New England Journal of Medicine editorial by UCI Health physicians highlights the need for clinicians to fully present opportunities and ethical choices to patients who face end-stage renal failure. The editorial, “Ensuring choice for people with kidney failure — dialysis, supportive care, and hope,” by Kamyar Kalantar-Zadeh, MD, MPH…

So You Discovered Something that Might Save Lives … Now What?

UC San Diego Health — July 16, 2020

New UC San Diego Dissemination and Implementation Science Center provides researchers and practitioners with the training, technical assistance, mentoring and resources needed to implement their findings in real-world settings.

So You Discovered Something that Might Save Lives … Now What?

UC San Diego Health — July 16, 2020

New UC San Diego Dissemination and Implementation Science Center provides researchers and practitioners with the training, technical assistance, mentoring and resources needed to implement their findings in real-world settings

UCI Health clinical trial targets recurrent AML

UCI Health — July 14, 2020

The UCI Health Chao Family Comprehensive Cancer has launched a first-in-the-nation clinical trial combining two recently approved drugs to prevent recurrence of adult acute myeloid leukemia (AML) in patients with myelodysplastic changes or therapy-related AML. The investigator-initiated clinical trail led by oncologist Dr. Deepa Jeyakumar is adding the stem-cell drug…

Health Media Contacts

Find the best contact for health-related media inquiries.

View All Media Contacts